- Home
- BWXT vs RVMD Comparison
BWXT vs RVMD Comparison
Compare BWXT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWXT
- RVMD
- Stock Information
- Founded
- BWXT 1867
- RVMD 2014
- Country
- BWXT United States
- RVMD United States
- Employees
- BWXT N/A
- RVMD N/A
- Industry
- BWXT
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWXT
- RVMD Health Care
- Exchange
- BWXT Nasdaq
- RVMD Nasdaq
- Market Cap
- BWXT 10.9B
- RVMD 8.7B
- IPO Year
- BWXT N/A
- RVMD 2020
- Fundamental
- Price
- BWXT $117.24
- RVMD $45.41
- Analyst Decision
- BWXT Strong Buy
- RVMD Strong Buy
- Analyst Count
- BWXT 8
- RVMD 13
- Target Price
- BWXT $124.57
- RVMD $62.77
- AVG Volume (30 Days)
- BWXT 726.0K
- RVMD 2.0M
- Earning Date
- BWXT 11-04-2024
- RVMD 11-06-2024
- Dividend Yield
- BWXT 0.82%
- RVMD N/A
- EPS Growth
- BWXT 24.26
- RVMD N/A
- EPS
- BWXT 3.02
- RVMD N/A
- Revenue
- BWXT $2,682,902,000.00
- RVMD $742,000.00
- Revenue This Year
- BWXT $9.56
- RVMD N/A
- Revenue Next Year
- BWXT $6.33
- RVMD $1,855.42
- P/E Ratio
- BWXT $39.10
- RVMD N/A
- Revenue Growth
- BWXT 12.02
- RVMD N/A
- 52 Week Low
- BWXT $74.69
- RVMD $25.60
- 52 Week High
- BWXT $136.31
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- BWXT 36.03
- RVMD 30.77
- Support Level
- BWXT $117.15
- RVMD $44.46
- Resistance Level
- BWXT $124.86
- RVMD $46.15
- Average True Range (ATR)
- BWXT 2.68
- RVMD 2.05
- MACD
- BWXT -1.39
- RVMD -0.71
- Stochastic Oscillator
- BWXT 7.65
- RVMD 3.93
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.